Skeletal muscle wasting can be characterized by systemic and local changes that consist of inflammation or other circulating biomarkers. Furthermore, skeletal muscle is able to synthesize and secrete several proteins with signaling functions that may be associated with changes in muscle mass due to nutrition, exercise, or pharmacological treatments. The identification of these biomarkers and the influence on skeletal muscle signaling could lead to the attenuation of muscle wasting in underlying issues such as cancer, aging, disuse, nerve injury, or other myopathies.
This Research Topic welcomes original research including experimental papers involving animal models and review articles covering:
1. The identification biomarkers of skeletal muscle wasting.
2. The identification of clinical or translational signaling related to skeletal muscle wasting.
3. The effect of nutrition, supplements, pharmacological interventions, or exercise on skeletal muscle wasting.
Skeletal muscle wasting can be characterized by systemic and local changes that consist of inflammation or other circulating biomarkers. Furthermore, skeletal muscle is able to synthesize and secrete several proteins with signaling functions that may be associated with changes in muscle mass due to nutrition, exercise, or pharmacological treatments. The identification of these biomarkers and the influence on skeletal muscle signaling could lead to the attenuation of muscle wasting in underlying issues such as cancer, aging, disuse, nerve injury, or other myopathies.
This Research Topic welcomes original research including experimental papers involving animal models and review articles covering:
1. The identification biomarkers of skeletal muscle wasting.
2. The identification of clinical or translational signaling related to skeletal muscle wasting.
3. The effect of nutrition, supplements, pharmacological interventions, or exercise on skeletal muscle wasting.